Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NO and COX2: Dual targeting for aggressive cancers.

Literature DB >> 29237749

NO and COX2: Dual targeting for aggressive cancers.

Daniel Davila-Gonzalez¹, Jenny C Chang¹, Timothy R Billiar².

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2017 PMID： 29237749 PMCID： PMC5748226 DOI： 10.1073/pnas.1717440114

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

22 in total

Review 1. Nitric oxide and cancer therapy: the emperor has NO clothes.

Authors: Jason R Hickok; Douglas D Thomas
Journal: Curr Pharm Des Date: 2010 Impact factor: 3.116

Review 2. The role of nitric oxide in tumour progression.

Authors: Dai Fukumura; Satoshi Kashiwagi; Rakesh K Jain
Journal: Nat Rev Cancer Date: 2006-07 Impact factor: 60.716

3. Perivascular nitric oxide gradients normalize tumor vasculature.

Authors: Satoshi Kashiwagi; Kosuke Tsukada; Lei Xu; Junichi Miyazaki; Sergey V Kozin; James A Tyrrell; William C Sessa; Leo E Gerweck; Rakesh K Jain; Dai Fukumura
Journal: Nat Med Date: 2008-02-17 Impact factor: 53.440

4. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.

Authors: A J Marrogi; W D Travis; J A Welsh; M A Khan; H Rahim; H Tazelaar; P Pairolero; V Trastek; J Jett; N E Caporaso; L A Liotta; C C Harris
Journal: Clin Cancer Res Date: 2000-12 Impact factor: 12.531

5. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes.

Authors: D A Geller; C J Lowenstein; R A Shapiro; A K Nussler; M Di Silvio; S C Wang; D K Nakayama; R L Simmons; S H Snyder; T R Billiar
Journal: Proc Natl Acad Sci U S A Date: 1993-04-15 Impact factor: 11.205

6. PBISe, a novel selenium-containing drug for the treatment of malignant melanoma.

Authors: SubbaRao V Madhunapantula; Dhimant Desai; Arati Sharma; Sung Jin Huh; Shantu Amin; Gavin P Robertson
Journal: Mol Cancer Ther Date: 2008-05 Impact factor: 6.261

7. Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance.

Authors: Marc Hennequart; Luc Pilotte; Stefania Cane; Delia Hoffmann; Vincent Stroobant; Etienne De Plaen; Benoît Van den Eynde
Journal: Cancer Immunol Res Date: 2017-07-21 Impact factor: 11.151

8. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.

Authors: Sergio Granados-Principal; Yi Liu; Maria L Guevara; Elvin Blanco; Dong Soon Choi; Wei Qian; Tejal Patel; Angel A Rodriguez; Joseph Cusimano; Heidi L Weiss; Hong Zhao; Melissa D Landis; Bhuvanesh Dave; Steven S Gross; Jenny C Chang
Journal: Breast Cancer Res Date: 2015-02-22 Impact factor: 6.466

9. Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity.

Authors: C Göbel; F Breitenbuecher; H Kalkavan; P S Hähnel; S Kasper; S Hoffarth; K Merches; H Schild; K S Lang; M Schuler
Journal: Cell Death Dis Date: 2014-12-11 Impact factor: 8.469

10. Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells.

Authors: Chen Yao; Ying Lin; Mei-Sze Chua; Cai-Sheng Ye; Jiong Bi; Wen Li; Yi-Fan Zhu; Shen-Ming Wang
Journal: Int J Cancer Date: 2007-11-01 Impact factor: 7.396

9 in total

1. Tumor-associated macrophages induce invasion and poor prognosis in human gastric cancer in a cyclooxygenase-2/MMP9-dependent manner.

Authors: Ji Xu; Yajuan Yu; Xujun He; Nan Niu; Xiao Li; Renchao Zhang; Junfeng Hu; Jie Ma; Xiaojun Yu; Yuanshui Sun; Haibin Ni; Fengyong Wang
Journal: Am J Transl Res Date: 2019-09-15 Impact factor: 4.060

2. A naturally derived small molecule PSM0537 targets the AF1Q-TCF4 interaction to suppress COX2 expression and inhibit cell proliferation and metastasis in osteosarcoma.

Authors: Ning Duan; Wentao Zhang; Tao Song; Zhong Li; Xun Chen; Wei Ma
Journal: Am J Cancer Res Date: 2021-06-15 Impact factor: 6.166

3. Soluble Fraction from Lysates of Selected Probiotic Strains Differently Influences Re-Epithelialization of HaCaT Scratched Monolayer through a Mechanism Involving Nitric Oxide Synthase 2.

Authors: Francesca Lombardi; Paola Palumbo; Antonella Mattei; Francesca Rosaria Augello; Maria Grazia Cifone; Maurizio Giuliani; Benedetta Cinque
Journal: Biomolecules Date: 2019-11-21

4. S-nitrosylated and non-nitrosylated COX2 have differential expression and distinct subcellular localization in normal and breast cancer tissue.

Authors: Sonali Jindal; Nathan D Pennock; Alex Klug; Jayasri Narasimhan; Andrea Calhoun; Michelle R Roberts; Rulla M Tamimi; A Heather Eliassen; Sheila Weinmann; Virginia F Borges; Pepper Schedin
Journal: NPJ Breast Cancer Date: 2020-11-24

5. CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality.

Authors: Carlo Sorrentino; Luigi D'Antonio; Stefania Livia Ciummo; Cristiano Fieni; Lorena Landuzzi; Francesca Ruzzi; Simone Vespa; Paola Lanuti; Lavinia Vittoria Lotti; Pier Luigi Lollini; Emma Di Carlo
Journal: J Hematol Oncol Date: 2022-10-13 Impact factor: 23.168

9. Unusual Secondary Metabolites of the Aerial Parts of Dionysia diapensifolia Bioss. (Primulaceae) and Their Anti-Inflammatory Activity.

Authors: Mostafa Alilou; Stefania Marzocco; Hossein Batooli; Jakob Troppmair; Stefan Schwaiger; Hermann Stuppner
Journal: Biomolecules Date: 2020-03-12